Ads
related to: mucosal barrier in stomach cancer treatment- Dosing Schedules
Find Dosing Info To Get Patients
Started On A UGI Cancer Therapy.
- Mechanism Of Action
Explore The MOA Of A UGI Therapy
To Learn How It Works.
- Treatment Modifications
View Recommended Dose Modifications
To Manage Adverse Reactions.
- Prep & Admin Info
View Preparation And Administration
Info For This 1L Therapy.
- HCP & Patient Resources
See Healthcare Provider & Patient
Resources For This Therapy Option.
- Safety Profile
See The Selected Safety Profile For
Gastroesophageal Cancers.
- Dosing Schedules
Search results
Results From The WOW.Com Content Network
The gastric mucosal barrier is the property of the stomach that allows it to safely contain the gastric acid required for digestion. If the barrier is broken, as by acetylsalicylic acid (ASA, aspirin) in acid solution, acid diffuses back into the mucosa where it can cause damage to the stomach itself.
Mucositis is the painful inflammation and ulceration of the mucous membranes lining the digestive tract, usually as an adverse effect of chemotherapy and radiotherapy treatment for cancer. [1] Mucositis can occur anywhere along the gastrointestinal (GI) tract, but oral mucositis refers to the particular inflammation and ulceration that occurs ...
A gastric cytoprotectant is any medication that combats ulcers not by reducing gastric acid but by increasing mucosal protection. [ citation needed ] Examples of gastric cytoprotective agents include prostaglandins which protect the stomach mucosa against injury by increasing gastric mucus secretion.
Progression of epithelial cancer often relies on deep and regional lymph node invasion. [12] The lamina propria, being one of the barriers to the submucosa, is an area where epithelial cancer invasion is of significance since lymphatic invasion is an independent predictor of lymph node metastasis , especially in gastric cancer . [ 13 ]
MALT lymphoma (also called MALToma) is a form of lymphoma involving the mucosa-associated lymphoid tissue (MALT), frequently of the stomach, but virtually any mucosal site can be affected. It is a cancer originating from B cells in the marginal zone of the MALT.
Gut-associated lymphoid tissue (GALT) [1] is a component of the mucosa-associated lymphoid tissue (MALT) which works in the immune system to protect the body from invasion in the gut. Owing to its physiological function in food absorption, the mucosal surface is thin and acts as a permeable barrier to the interior of the body.
Ads
related to: mucosal barrier in stomach cancer treatment